drugset / Trial / NCT04498884

Comparative Study of the Pharmacokinetics of Rinsulin® Mix 30/70, Suspension for Subcutaneous Administration, 100 IU / ml (OJSC GEROPHARM-Bio, Russia) and Humulin® M3, Suspension for Subcutaneous Administration, 100 IU / ml (Lilly France, France) Using the Euglycemic Hyperinsulinemic Clamp Method

NCT04498884 ↗

Completed 32 enrolled Geropharm
RandomizedCrossoverDouble-blindBasic science

Summary

Pharmacokinetics and pharmacodynamics study of 2 formulations of insulin mixtures Rinsulin® Mix 30/70, Suspension for Subcutaneous Administration, 100 IU / ml (OJSC GEROPHARM-Bio, Russia) versus Humulin® M3, Suspension for Subcutaneous Administration, 100 IU / ml (Lilly France, France).

Timeline

Start
2017-07-18
Primary completion
2017-10-24
Completion
2017-10-24

Drugs

EvaluationDrugModalityDoseRoute
Subject Humulin® M3 Unknown 0.4 iu/kg Subcutaneous
Subject Rinsulin® mix 30/70 Unknown 0.4 iu/kg Subcutaneous

Indications

No indication recorded.